A leading provider of innovative, minimally invasive medical devices used by healthcare providers for vascular access, peripheral vascular disease, and oncology
Congratulations to this year's President's Club inductees! Thank you for your dedication to AngioDynamics and showing your team what it means to be mission-ready.
Kelly Pittman
Jason Scocchera
Mark Weser
Matt Harris
Duane Anderson
Jaclene Corstorphine
Chloe Kimmey
Adnan Khan
Marcus Smith
Alicia Painter
Dean Rutledge
Bradd Mellion
Nathan Cochran
Greg Walker
Brooke Cooksey
Erick Brantley
Mandy Tharp
Ali Densmore
Tom Miller
Carrie Hutton
Jeff Oestereich
Ben Pincus
Tim Snider
Jared Rochelle
Cliff Lane
Kyle Kersey
Elizabeth Hancock
Laura Stout
Pete Makula
Chantal Souligny
Gilberto Bregantim
Kizy Sorato Tavares
Ryan Tracy
KerryAnn Thompson
Kelly Deerfield
Margeaux Hayden
#AngioDynamics #teamangio #allsystemsgo #employeerecognition #presidentsclub
We are excited to launch our annual Global Sales Meeting (GSM) this Thursday. This event will bring together leadership, sales, clinical, and marketing teams from all regions to collaborate, reflect on last year’s performance, and develop strategies for the upcoming year aimed at strengthening physician partnerships and improving patient care.
The theme “All Systems Go” is the signal that preparation has met opportunity. Just like a successful space launch, every system matters — our people, our strategy, our innovation, and our execution. When we are aligned and mission-ready, there’s no limit to how far we can go.
Stay tuned to our social profiles to hear more from GSM!
#Angiodynamics #patientcare #meddevice
For over 30 years, Soft-Vu Angiographic Catheters have been a trusted choice for physicians. Visit our website or connect with a sales representative to learn more about what sets Soft-Vu apart from other angiographic catheters.
Visit us: https://t.co/vXLbQIfj3k
Risk info: https://t.co/JmrcEzjwnl
#SoftVu #AngioDynamics #PatientCare
Thoughtful design and dependable access for long-term therapy - the BioFlo implantable port with Endexo technology.
Visit us: BioFlo Ports | AngioDynamics
Risk info: Medical Technologies and Devices Risk Information | AngioDynamics
#BioFloPorts#EndexoTechnology #AngioDynamics #PatientCare
1. The reduction in thrombus accumulation (based on platelet count) is supported by acute in-vitro testing. Pre-clinical in-vitro evaluations do not necessarily predict clinical performance with respect to thrombus formation.
2. Based on benchtop testing performed up to two hours using bovine blood, which may not be indicative of clinical results. Data on file.
With over 50 different tip shapes, Soft-Vu Angiographic Catheters are ready for any challenge. Want to learn more?
Visit us: https://t.co/Hd0vgeuN4a
Risk info: https://t.co/XRzPxP6tIZ
#SoftVu#AngioDynamics#PatientCare
SmartPort+ implantable ports with Endexo technology have the potential to reduce thrombus, fibrin sheath, and clot formations, potentially leading to lower procedural costs and improved patient outcomes.
Make the switch to SmartPort+ implantable ports and see the difference.
For full risk information, please visit: https://t.co/HxY5N3nptJ.
#smartport+ #angiodynamics
We recognize the unwavering dedication, compassion, and expertise nurses bring to healthcare every day. Your commitment to patients and the resilience you show in every challenge inspire all of us.
We’re honored to support your work.
This week and always, we celebrate you.
Precision you can trust. Learn more about how accurate and dependable Accu-Vu® Sizing Angiographic Catheters are.
Visit us: https://t.co/Hd0vgeuN4a
Risk info: https://t.co/XRzPxP6tIZ
#AccuVu#AngioDynamics#PatientCare
🚀 AngioDynamics is Hiring – Territory Manager, Oncology (NanoKnife) | Denver, CO
AngioDynamics is hiring in our Oncology division and we are looking for a driven Territory Manager to support the Denver, CO markets. This role focuses on expanding adoption of our innovative NanoKnife System, the only function-preserving therapy that uses electricity to destroy prostate tumors.
This is an exciting opportunity to partner with leading physicians and health systems while bringing advanced tumor treatment technology to patients who need it most.
In this role, you will:
• Drive territory growth and expand adoption of the NanoKnife platform
• Build strong partnerships with surgeons, interventional specialists, and hospital teams
• Provide procedural support and clinical expertise during cases
• Deliver product education and training to clinical staff
• Develop and execute strategic territory plans to grow the oncology business
We’re seeking a motivated sales professional with experience in oncology, surgical oncology, urology, or interventional medical devices who thrives in a clinical, fast-paced environment.
📩 Apply today or message me for more details! https://t.co/f3TQ2KWaFU
#AngioDynamics #NanoKnife #MedicalDevices #OncologySales #TerritoryManager #Hiring #DenverJobs #SalesCareers
It may look like a smile – and honestly, it fits.
The kink-resistant shaft is designed to recover rapidly, even when it’s bent, twisted, or knotted, helping maintain freer flow and clog-free drainage.
A catheter that keeps its shape gives everyone a reason to smile.
Visit us: Drainage Catheters | AngioDynamics
Risk info: Medical Technologies and Devices Risk Information | AngioDynamics
Click the link to find a sales rep near you ▶️ https://t.co/nlkKqS2orq
#TotalAbscession #DrainageCatheter #AngioDynamics #PatientCare
Supporting long‑term therapy with thoughtful design and dependable access — the BioFlo implantable port with Endexo technology.
Visit us: BioFlo Ports | AngioDynamics
Risk info: Medical Technologies and Devices Risk Information | AngioDynamics
#BioFloPorts#EndexoTechnology #AngioDynamics #PatientCare
1. The reduction in thrombus accumulation (based on platelet count) is supported by acute in-vitro testing. Pre-clinical in-vitro evaluations do not necessarily predict clinical performance with respect to thrombus formation.
2. Based on benchtop testing performed up to two hours using bovine blood, which may not be indicative of clinical results. Data on file
The most important takeaway from SIR The conversations.
SIR 2026 reinforced something we believe deeply: real innovation starts with physicians.
From complex case discussions to workflow challenges, the insights shared in Toronto continue to shape how we think about supporting minimally invasive care not just with technology, but with solutions that fit the realities of practice.
Thank you to everyone who spent time with us.
Your perspective drives how we move forward.
We are committed to continuing this work together.
See you next year.
#AngioDynamics #SIR26TOR
Precision you can see with your own eyes. Learn more about how accurate and dependable Accu-Vu® Sizing Angiographic Catheters are.
Visit us: https://t.co/Hd0vgeuN4a
Risk info: https://t.co/XRzPxP6tIZ
#AccuVu#AngioDynamics#PatientCare
Progress in minimally invasive care does not happen in isolation.
It is built case by case. Decision by decision. Physician by physician.
At the SIR 2026 Annual Scientific Meeting, we are joining the clinical community to focus on what matters most, helping you navigate complexity with confidence, from access to targeted treatment.
Our approach is simple: support physicians with solutions that work across procedures, streamline workflows, and expand the possibilities in minimally invasive care.
If you are thinking about how to
• optimize procedural efficiency
• adapt to increasingly complex cases
• improve outcomes without adding burden
Let’s connect.
📍 Visit us at booth #523
#AngioDynamics #SIR26TOR
Visit the AngioDynamics booth while you’re at SIR and see why our Soft-Vu and Accu-Vu angiographic catheters could be the right choice for your patients.
View our portfolios: https://t.co/gQ7u0gHMqu
We’re excited to support hands-on learning at the Society of Interventional Radiology (SIR) Annual Meeting during the ablation-focused skills training session on April 14 at 9:15 AM.
As part of this multi-modality course, participants will gain practical exposure to irreversible electroporation (IRE) using NanoKnife technology, exploring the role of non-thermal electrical energy in focal soft-tissue ablation.
We look forward to connecting with you!
Risk Info: https://t.co/xxrwO128W1